Ka. Webster et al., CARDIOPROTECTION IN AN IN-VITRO MODEL OF HYPOXIC PRECONDITIONING, Journal of Molecular and Cellular Cardiology, 27(1), 1995, pp. 453-458
Short periods of myocardial ischemia appear to provide protection agai
nst subsequent prolonged ischemic episodes in experimental animals and
in man. This phenomenon, known as ischemic preconditioning, has not y
et been characterized at the cellular or molecular levels; however, ti
ssue hypoxia appears to be required. In this study, we used a previous
ly developed method for hypoxic cardiac myocyte culture in order to es
tablish a model for ischemic (or hypoxic) preconditioning in cell cult
ure. We demonstrate that cultured neonatal rat cardiac myocytes precon
ditioned by 25 min of exposure to hypoxia followed by reoxygenation we
re protected against membrane damage for up to 6 h of prolonged severe
hypoxia, as determined by arachidonic acid release and contractile re
covery. In contrast, non-preconditioned myocytes exhibited significant
hypoxic damage after 2-4 h. Pretreatment of cells with PMA, a tumor-p
romoting phorbol ester, mimicked the protective effects of hypoxic pre
conditioning; pretreatment with the muscarinic cholinergic agonist car
bachol had no effect, Our data suggests that isolated myocytes in cult
ure remain competent to be preconditioned by hypoxia, through a pathwa
y that may involve the activation of protein kinase C.